These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16221689)

  • 1. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients.
    Morimoto H; Nakao K; Fukuoka K; Sarai A; Yano A; Kihara T; Fukuda S; Wada J; Makino H
    Nephrol Dial Transplant; 2005 Dec; 20(12):2775-82. PubMed ID: 16221689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
    Panichi V; Rosati A; Paoletti S; Ferrandello P; Migliori M; Beati S; Bernabini G; Daini R; Casani A; Angelini D; Parrini M; Rossi A; Petrone I; Barsotti G; Donadio C; Donati G; Grazi G; Manca Rizza G; Garosi G; Sansoni E; Braccagni B; Sidoti A; Boracelli D; Biagioli M; Moriconi L; Finato V; Mannarino A; Grimaldi C; Pansa F; Imperiali P; Mura C; Bianchi S; Bigazzi R
    Blood Purif; 2011; 32(1):7-14. PubMed ID: 21242686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profile.
    Morena M; Gausson V; Mothu N; Bouchet JL; Chanas M; Grandvuillemin M; Robert A; Vela C; Canaud B; Cristol JP; Olmer M
    Blood Purif; 2008; 26(3):300-10. PubMed ID: 18451643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis.
    Kirmizis D; Papagianni A; Belechri AM; Memmos D
    Nephrol Dial Transplant; 2011 Jul; 26(7):2296-301. PubMed ID: 21127134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress.
    Takouli L; Hadjiyannakos D; Metaxaki P; Sideris V; Filiopoulos V; Anogiati A; Vlassopoulos D
    Ren Fail; 2010 Jan; 32(3):287-93. PubMed ID: 20370442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.
    Kielstein JT; Böger RH; Bode-Böger SM; Schäffer J; Barbey M; Koch KM; Frölich JC
    J Am Soc Nephrol; 1999 Mar; 10(3):594-600. PubMed ID: 10073610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters.
    Satoh M; Yamasaki Y; Nagake Y; Kasahara J; Hashimoto M; Nakanishi N; Makino H
    Kidney Int; 2001 May; 59(5):1943-50. PubMed ID: 11318967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: a pilot study.
    Chang JW; Lee EK; Kim TH; Min WK; Chun S; Lee KU; Kim SB; Park JS
    Am J Nephrol; 2007; 27(1):70-4. PubMed ID: 17259696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
    Nanayakkara PW; Kiefte-de Jong JC; ter Wee PM; Stehouwer CD; van Ittersum FJ; Olthof MR; Teerlink T; Twisk JW; van Guldener C; Smulders YM
    Am J Kidney Dis; 2009 Jan; 53(1):41-50. PubMed ID: 18786751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure.
    Tsuruoka S; Kawaguchi A; Nishiki K; Hayasaka T; Fukushima C; Sugimoto K; Saito T; Fujimura A
    Am J Kidney Dis; 2002 Jan; 39(1):127-33. PubMed ID: 11774111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients.
    Mune M; Yukawa S; Kishino M; Otani H; Kimura K; Nishikawa O; Takahashi T; Kodama N; Saika Y; Yamada Y
    Kidney Int Suppl; 1999 Jul; 71():S126-9. PubMed ID: 10412755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E-Bonded Membranes Do Not Influence Markers of Oxidative Stress in Hemodialysis Patients with Homozygous Glutathione Transferase M1 Gene Deletion.
    Djuric P; Suvakov S; Simic T; Markovic D; Jerotic D; Jankovic A; Bulatovic A; Tosic Dragovic J; Damjanovic T; Marinkovic J; Naumovic R; Dimkovic N
    Toxins (Basel); 2020 May; 12(6):. PubMed ID: 32471186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E-coated polysulfone membrane improved red blood cell antioxidant status in hemodialysis patients.
    Bargnoux AS; Cristol JP; Jaussent I; Chalabi L; Bories P; Dion JJ; Henri P; Delage M; Dupuy AM; Badiou S; Canaud B; Morena M
    J Nephrol; 2013; 26(3):556-63. PubMed ID: 22956433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
    Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH
    Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans.
    Nakamura T; Kawagoe Y; Matsuda T; Takahashi Y; Sekizuka K; Ebihara I; Koide H
    Kidney Blood Press Res; 2003; 26(3):185-91. PubMed ID: 12886046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of vitamin E-coated membrane dialyzer compared to simvastatin in patients on chronic hemodialysis.
    Kirmizis D; Papagianni A; Dogrammatzi F; Belechri AM; Alexopoulos E; Efstratiadis G; Memmos D
    Ren Fail; 2012; 34(9):1135-9. PubMed ID: 22950641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antioxidants and malondialdehyde during hemodialysis with cellulose diacetate and polysulfone membranes].
    Eiselt J; Racek J; Holecek V; Krejcová I; Opatrný K
    Cas Lek Cesk; 1996 Nov; 135(21):691-4. PubMed ID: 8998818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy.
    O'Byrne D; Devaraj S; Islam KN; Collazo R; McDonald L; Grundy S; Jialal I
    Metabolism; 2001 Feb; 50(2):207-15. PubMed ID: 11229431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients.
    Nguyen-Khoa T; Massy ZA; Witko-Sarsat V; Thévenin M; Touam M; Lambrey G; Lacour B; Drüeke TB; Descamps-Latscha B
    Kidney Int; 1999 Aug; 56(2):747-53. PubMed ID: 10432417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.